KẾT QUẢ ĐIỀU TRỊ BỆNH LÝ LẠC NỘI MẠC TỬ CUNG TẠI BỆNH VIỆN PHỤ SẢN NAM ĐỊNH NĂM 2025

Abstract

Objectives: The goal of this study is to assess the clinical and paraclinical features of endometriosis, as well as the treatment outcomes, at Nam Dinh Obstetrics and Gynecology Hospital in 2025.

Subjects and methods: From January to December 2025, a cross-sectional descriptive study was conducted on 48 endometriosis patients who were diagnosed and treated.

Results: The average age of the study participants was 32.6 ± 5.8. Dysmenorrhea was the most prevalent symptom (79.2%), with 16.7% having acute pain near prior surgical scars and 31.3% seeking infertility therapy. According to location, ovarian endometriosis accounted for 45.8%, uterine myocardium 25.0%, abdominal wall endometriosis 16.7%, and perineum endometriosis 10.4%. Cystic lesions were found on ultrasound in 45.8% of cases. In terms of treatment, medicinal treatment was the most popular, with Dienogest accounting for 91.6%; surgical and combination treatments accounted for a small fraction. The efficiency in relieving pain symptoms was 91.7%, while the rate of early recurrence within 6 months was 2.1%.

Conclusion: Endometriosis in Nam Dinh manifests in a variety of lesion locations, including extrauterine areas such as the abdominal wall and perineum. Medical treatment with hormonal medications is now the most effective alternative for patients, offering significant relief from pain sensations.